Palisade Capital Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Palisade Capital Management’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,241,810	Closed	-$25.8M	–	415
2022 Q2	$25.8M	Sell	1,241,810 -571,721	-32%	-$10.2M	0.7%	48
2022 Q1	$30.4M	Sell	1,813,531 -82,497	-4%	-$1.44M	0.7%	41
2021 Q4	$37.9M	Buy	1,896,028 +115,117	+6%	+$2.17M	0.77%	35
2021 Q3	$32.3M	Buy	1,780,911 +640,381	+56%	+$14.7M	0.71%	40
2021 Q2	$30.8M	Sell	1,140,530 -11,721	-1%	-$328K	0.69%	41
2021 Q1	$34.5M	Buy	1,152,251 +144,146	+14%	+$4.92M	0.81%	32
2020 Q4	$29M	Sell	1,008,105 -39,783	-4%	-$1.07M	0.74%	36
2020 Q3	$25.6M	Buy	1,047,888 +127,828	+14%	+$2.76M	0.76%	29
2020 Q2	$16.5M	Buy	920,060 +4,589	+0.5%	+$60.3K	0.52%	62
2020 Q1	$7.45M	Buy	915,471 +48,840	+6%	+$558K	0.26%	129
2019 Q4	$11.4M	Buy	866,631 +261,752	+43%	+$3.17M	0.32%	107
2019 Q3	$7.19M	Buy	+604,879	New	+$11.2M	0.22%	132

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Palisade Capital Management's CVET Position: Q3 2022 in Review

Palisade Capital Management sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 1,241,810 shares — an estimated $25.8M sold.

Palisade Capital Management first reported a position in CVET in Q3 2019 and held it in 12 quarters. The position peaked at $37.9M in Q4 2021. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

Palisade Capital Management reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Palisade Capital Management sold 1,241,810 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $25.8M.
Palisade Capital Management first reported a position in Covetrus, Inc. Common Stock in Q3 2019 and held it in 12 quarters.
Palisade Capital Management's Covetrus, Inc. Common Stock position peaked at $37.9M in Q4 2021.
250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Palisade Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.